Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun;39(6):1083-1090.
doi: 10.1097/IAE.0000000000002114.

THREE-YEAR OUTCOMES IN A RANDOMIZED SINGLE-BLIND CONTROLLED TRIAL OF INTRAVITREAL RANIBIZUMAB AND ORAL SUPPLEMENTATION WITH DOCOSAHEXAENOIC ACID AND ANTIOXIDANTS FOR DIABETIC MACULAR EDEMA

María Lafuente  1 , Lourdes Ortín  1 , María Argente  1 , José L Guindo  1 , María D López-Bernal  1 , Francisco J López-Román  2 , Joan Carles Domingo  3 , Jerónimo Lajara  1   2
Affiliations

THREE-YEAR OUTCOMES IN A RANDOMIZED SINGLE-BLIND CONTROLLED TRIAL OF INTRAVITREAL RANIBIZUMAB AND ORAL SUPPLEMENTATION WITH DOCOSAHEXAENOIC ACID AND ANTIOXIDANTS FOR DIABETIC MACULAR EDEMA

María Lafuente et al. Retina. 2019 Jun.

Abstract

Purpose: To report 3-year results of a randomized single-blind controlled trial of intravitreal ranibizumab combined with oral docosahexaenoic acid (DHA) supplementation versus ranibizumab alone in patients with diabetic macular edema.

Methods: There were 26 patients (31 eyes) in the DHA group and 29 (38 eyes) in the control group. Ranibizumab (0.5 mg) was administered monthly for the first 4 months followed by a pro re nata (PRN) regimen. In the experimental group, patients received oral DHA supplementation (1,050 mg/day) (Brudyretina 1.5 g).

Results: At 36 months, mean decrease of central subfield macular thickness was higher in the DHA-supplementation group than in controls (275 ± 50 μm vs. 310 ± 97 μm) with significant differences at Months 25, 30, 33, and 34. Between-group differences in best-corrected visual acuity were not found, but the percentages of ETRDS gains >5 and >10 letters were higher in the DHA-supplementation group. Differences serum HbA1c, plasma total antioxidant capacity values, erythrocyte DHA content, and serum IL-6 levels were all significant in favor of the DHA-supplementation group.

Conclusion: The addition of a high-rich DHA dietary supplement to intravitreal ranibizumab was effective to achieve better sustained improvement of central subfield macular thickness outcomes after 3 years of follow-up as compared with intravitreal ranibizumab alone.

PubMed Disclaimer

Conflict of interest statement

None of the authors has conflicting interests to disclose.

Figures

Fig. 1.
Fig. 1.
Flowchart of the study patients and eyes.
Fig. 2.
Fig. 2.
A. Changes of CSMT from the baseline to 36 months after treatment with DHA supplementation as compared with controls (asterisk indicates statistically significant differences P < 0.05) (DHA-supplementation group: black line; control group: gray line). B. Changes in ETDRS BCVA letters in the DHA-supplementation group and in controls (DHA-supplementation group: black line; control group: gray line).
Fig. 3.
Fig. 3.
A. Increases in TAC in the two study groups (basal: black bar; 12 months: gray bar; 24 months: dark gray bar; 36 months: light gray bar). B. Changes of serum IL-6 levels in the experimental (DHA supplementation) and control groups (basal: black bar; 36 months: gray bar).
See this image and copyright information in PMC

References

    1. Willis JR, Doan QV, Gleeson M, et al. Vision-related functional burden of diabetic retinopathy across severity levels in the United States. JAMA Ophthalmol 2017;135:926–932. - PMC - PubMed
    1. Das A, McGuire PG, Rangasamy S. Diabetic macular edema: pathophysiology and novel therapeutic targets. Ophthalmology 2015;122:1375–1394. - PubMed
    1. Cai J, Boulton M. The pathogenesis of diabetic retinopathy: old concepts and new questions. Eye 2000;16:242–260. - PubMed
    1. SanGiovanni JP, Chew EY. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res 2005;24:87–138. - PubMed
    1. Shindou H, Koso H, Sasaki J, et al. Docosahexaenoic acid preserves visual function by maintaining correct disc morphology in retinal photoreceptor cells. J Biol Chem 2017;292:1054–1064. - PMC - PubMed

MeSH terms